In life sciences capital projects, commissioning will continue to be one of the most critical, and often underestimated, contributors to successful delivery. Too often, commissioning will be treated as a late‑stage activity, introduced once construction is complete. However, this approach repeatedly leads to delays, cost overruns and challenges in achieving operational readiness.
The Commissioning: Planning for Success webinar, presented by Blackfield Associates and ISPE, is hosted by Chris Leman, Capital Projects Global C&Q Lead at AstraZeneca. Along with our expert panel, Chris will explore how early, integrated commissioning planning will significantly improve project outcomes and reduce risk across the project lifecycle.
Expert panel
- Nick Haycocks, Consultant at RoNIK LLC
- Adam Harris, Commissioning Manager at AstraZeneca
- Gareth Knifght, Commissioning Manger
- Hilary Mills-Baker, ISPE Member
Led by Chris, our industry panel will focus on and guide us through three main themes, as outlined below.
Purpose and foundations of a commissioning plan
A robust commissioning plan defines resources, responsibilities, standards, dependencies, and success criteria. Our expert panel will discuss how, by planning with the end in mind, project teams ensure that early decisions support a compliant and efficient start‑up.
Integration, control and contractual alignment
We’ll look at how to achieve full integration and alignment, and improve visibility, accountability and predictability, thereby reducing late‑stage surprises and protecting delivery timelines.
Risk, resilience and measuring success
They’ll explore how clearly defined success criteria allow teams to measure whether the commissioning approach has achieved its intended outcomes, ensuring the facility is not only tested, but truly operationally ready and fit for purpose.
Sign up now
Register now to secure your place.
